Post-Coital Antibiotic Prophylaxis for Recurrent UTI
For non-pregnant adult women with recurrent UTIs related to sexual intercourse, post-coital antimicrobial prophylaxis is highly effective and should be offered when non-antimicrobial interventions have failed, using a single dose of trimethoprim-sulfamethoxazole (160/800 mg), nitrofurantoin (50-100 mg), cephalexin (250 mg), or ciprofloxacin (125 mg) taken within 2 hours after intercourse. 1
When to Offer Post-Coital Prophylaxis
Post-coital antimicrobial prophylaxis should be considered as a strong recommendation when non-antimicrobial interventions have been unsuccessful in preventing recurrent UTIs. 1 This approach is particularly appropriate for women whose UTI episodes are clearly temporally related to sexual activity. 2
Stepwise Approach Before Antibiotics
Before initiating antimicrobial prophylaxis, the following non-antimicrobial measures should be attempted first:
- Increased fluid intake (>1.5 L/day) in women with baseline intake below this threshold 3
- Cranberry products standardized to at least 36 mg proanthocyanidins, which can reduce UTI rates by 54% 3
- Methenamine hippurate 1 g twice daily as a non-antibiotic alternative 3, 1
- Vaginal estrogen in postmenopausal women (strong recommendation) 1
- Immunoactive prophylaxis across all age groups 1
Recommended Antibiotic Regimens
First-Line Options
The following single-dose post-coital regimens have demonstrated efficacy:
- Trimethoprim-sulfamethoxazole 160/800 mg: Highly effective with infection rates reduced from 3.6 to 0.3 per patient-year in randomized controlled trials 4, 2
- Nitrofurantoin 50-100 mg: Proven effective in post-coital prophylaxis with minimal resistance induction 2
- Cephalexin 250 mg: Reduced infections from 127 episodes (pre-treatment) to only 1 episode during 12 months of prophylaxis in 31 women 5
- Ciprofloxacin 125 mg: Equally effective as daily prophylaxis, reducing infections from 3.67 to 0.043 per patient 6
Timing and Administration
The antibiotic should be taken as a single dose within 2 hours after sexual intercourse. 4, 5, 2 This timing is critical as sexual intercourse transfers pre-existing introital bacteria into the bladder, typically causing UTI symptoms within 24 hours. 2
Efficacy and Advantages
Post-coital prophylaxis offers several key advantages:
- Equivalent efficacy to daily prophylaxis: Studies demonstrate no difference in infection prevention between post-coital and continuous daily regimens 7, 6, 5
- Reduced antibiotic consumption: Uses only one-third the amount of antibiotics compared to daily prophylaxis 6, 5
- Excellent compliance: Patients find this approach simple and economical 2
- Sustained benefit: The reduction in introital colonization with gram-negative bacteria (from 86% to 2.5-5.6%) persists even after prophylaxis ends 6
Duration of Prophylaxis
Prophylaxis should be maintained for 6-12 months initially. 7, 2 After this period, reassess the need for continuation based on:
- Recurrence patterns during prophylaxis
- Patient preference and compliance
- Persistence of risk factors 1
Important Caveats and Counseling Points
Patient Counseling
Patients must be counseled regarding:
- Possible side effects of antimicrobial prophylaxis 1
- The importance of taking the medication specifically after intercourse, not before
- Continued need for adequate hydration and other preventive measures 3
Common Pitfalls to Avoid
- Do not use sulfonamides alone for post-coital prophylaxis due to higher breakthrough infection rates 2
- Do not perform post-treatment urine cultures in asymptomatic patients 3, 1
- Do not add vitamin C (ascorbic acid) when using methenamine, as urine acidifiers do not enhance efficacy 3
- Avoid nalidixic acid as it is no longer recommended due to resistance patterns, despite historical efficacy 2
Monitoring
During prophylaxis, patients should be followed clinically and bacteriologically if symptoms develop. 6 However, routine surveillance cultures in asymptomatic patients are not indicated. 3
Alternative to Post-Coital Prophylaxis
For patients with good compliance who prefer more autonomy, self-administered short-term antimicrobial therapy at the first sign of symptoms should be considered as an alternative strategy. 1 This approach allows patients to initiate treatment immediately when symptoms begin, rather than taking prophylactic antibiotics.